Venture Valuations Are Normal Again — And That’s a Good Thing

After two years of recalibration, venture capital valuations have returned to something the market hasn’t seen in a while: historical norms. The distortion of 2021–2022 — characterized by outsized step-ups, inflated late-stage pricing, and compressed diligence cycles — has largely…








